NVIDIA and Apple have been quietly building something that could redefine spatial computing as we know it. At the center of this collaboration is NVIDIA CloudXR 6.0, technology that has the potential to dramatically expand what the Apple Vision Pro is capable of, shifting it from a powerful standalone device into a gateway for ultra-high-fidelity,ContinueContinue reading “Apple Vision Pro Just Took a Massive Leap with NVIDIA”
Author Archives: drrjv
Analysis: Apple’s Second Quarter 2026
Get educated on Apple with this summary of Horace Dediu’s analysis of Apple’s Fiscal Second Quarter 2026 performance. It highlights a company in a state of high-growth acceleration, driven by a “super cycle” in hardware and a foundational surge in Services, while navigating a significant leadership transition. Executive SummaryApple delivered a “comfortable beat” on bothContinueContinue reading “Analysis: Apple’s Second Quarter 2026”
The AI RoboDoctor Will See You Now
A Harvard-led study just dropped a result that will make every ER doctor’s stethoscope twitch. In a head-to-head against attending physicians at a Boston hospital, OpenAI’s o1-preview reasoning model diagnosed patients more accurately at the moment of triage, just when information is sparse, time is short, and getting it wrong can kill someone. The NumbersContinueContinue reading “The AI RoboDoctor Will See You Now”
Beyond Statins: A Smarter, Personalized Strategy to Reduce Cardiovascular Risk
About the Author I’m a retired neurologist who spent decades managing vascular disease and its consequences—stroke, cognitive decline, and disability. Much of that burden traces back to atherosclerosis. The science of lipid management has evolved dramatically, but everyday practice and public understanding have not kept pace. This piece distills what matters now: how to reduceContinueContinue reading “Beyond Statins: A Smarter, Personalized Strategy to Reduce Cardiovascular Risk”
What’s Wrong with US Health Care
The U.S. health system is fundamentally broken across several dimensions • Unaffordable: High costs burden both individuals (medical debt, especially for chronic illness) and the nation (nearly double per‑capita spending vs. peers). • Incomplete coverage: 27 million uninsured today, potentially rising to ~40 million due to policy changes. • Overly complex: Administrative hurdles—especially prior authorization—makeContinueContinue reading “What’s Wrong with US Health Care”
Why Apple’s New CEO is a Bet on System-Level Power
John Ternus’ defining achievement at Apple wasn’t a sleek new gadget—it was a brain transplant. Ternus leading the transition from Intel to Apple Silicon was a high-stakes gamble that required a total overhaul of hardware, software, and the developer ecosystem. In the tech world, shifts this massive usually break things. Ternus made it look effortless. As he takesContinueContinue reading “Why Apple’s New CEO is a Bet on System-Level Power”
Why do Honeybees Swarm?
Honeybee swarming is a natural and fascinating part of a colony’s life cycle. While it can look intimidating to see thousands of bees flying in a dark cloud, it is actually a sign of a healthy, thriving colony. Think of a swarm not as a group of bees “running away,” but as biological reproduction onContinueContinue reading “Why do Honeybees Swarm?”
Run a Chatbot Locally on your iPhone 
Running a chatbot locally on an iPhone means the AI model lives entirely on your device’s hardware (the processor and RAM) rather than a cloud server. This ensures total privacy and works without an internet connection. In 2026, the barrier to entry has dropped significantly thanks to powerful mobile chips and optimized apps. Here isContinueContinue reading “Run a Chatbot Locally on your iPhone ”
My Mother’s Memory
My mother is 103 years old. To live for over a century is a miracle, but it comes with a heavy tax. Her progressive dementia has reached a stage where language is slipping away. Her speech has become “gibberish” we can’t quite decode, and her once-prolific writing has slowed to a trickle of fragmented lines.ContinueContinue reading “My Mother’s Memory”
The Ozempic Era Grows Up
What the Latest NEJM Review Gets Right, and Glosses Over A Critique and Summary of the GLP-1 Receptor Agonists Review by Clifford J. Rosen and Julie R. Ingelfinger, published in NEJM ON April 2, 2026. The New England Journal of Medicine just published a sweeping review of GLP-1 receptor agonists, the class of drugs behindContinueContinue reading “The Ozempic Era Grows Up”
Dr Bob, Brain Mechanic 